Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1255966

Cover Image

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1255966

Porokeratosis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 6500
PDF (Enterprise License)
USD 9000

Add to Cart

Description

Table of Contents

List of Tables

The market for Porokeratosis Treatment is projected to expand at a CAGR of 7% during the forecast period of 2023 to 2031. Numerous factors, including an increase in renal transplant cases, improved reimbursement policies in developed nations, an increase in research funding, and intensifying competition among market participants, continue to contribute to the expansion of the global market. The porokeratosis treatment market is driven by a number of factors, such as the rising prevalence of the condition among healthcare professionals and patients. The rising prevalence of porokeratosis is a major factor driving the market for treatments for this condition. Porokeratosis is a rare disorder, but its incidence has increased in recent years due to factors such as increased UV radiation exposure and increased use of immunosuppressive drugs.

The growing awareness of porokeratosis among healthcare professionals and patients, resulting in an increasing demand for effective treatments for the condition, is also driving the market for porokeratosis treatments. As more individuals are diagnosed with porokeratosis, there is a growing need for information and education regarding the condition and its treatment. This is resulting in an increased demand for treatments and therapies that can help manage the symptoms of porokeratosis and improve the quality of life for those who have the condition. In addition, technological advancements in dermatology are driving the market. In addition, the development of new, more effective therapies and treatments for porokeratosis drives demand these products. This includes the development of new topical and systemic therapies, as well as new technologies such as photodynamic therapy and laser therapy. Increasing healthcare expenditures are also a market driver. Patients are more willing to invest in the treatment of porokeratosis due to growing awareness of the condition and the availability of new treatments. This is causing an increase in the number of patients seeking treatment for porokeratosis, as well as a corresponding rise in healthcare expenditures.

Increasing Prevalence of Superficial Disseminated Actinic Porokeratosis

Porokeratosis is a rare skin condition that affects fewer than two hundred thousand Americans. The most prevalent form of porokeratosis is the distribution of actinic porokeratosis (DSAP). The reported prevalence of DSAP ranges from 23% to 61.1%, whereas the reported incidence ranges from 12.6% to 43.4% annually. Due to these high prevalence and incidence rates, DSAP is the most frequently treated disorder in the United States. Mibelli The second most common type of porokeratosis is porokeratosis. Porokeratosis is a precancerous lesion that can transform into a cancerous growth. In 6.9% to 30% of reported cases, Pokerokeratosis progressed to non-melanoma skin cancer. About 8% of those affected by Mibelli's porokeratosis develop skin cancer, according to one study. With a median age of 3.5 years, 10.68% of kidney transplant patients in Spain developed porokeratosis in a single series.

As the incidence of porokeratosis in patients who have undergone a renal transplant rises, the market will be bolstered. In 2017, 10.68% of renal transplant recipients in the United States suffered from porokeratosis, according to a report. DSAP is a form of porokeratosis that primarily affects the forearms and legs as a result of excessive sun exposure. Almost 43.4% of women between 30 and 50 years old are diagnosed with DSAP, which is twice as prevalent in women as in men. There is a risk of developing squamous cell carcinomas at the affected site of the body in cases where DSAP is harmful.

There are numerous creams and gels for preventing infection, thereby expanding the market for treatment adoption. It is a rare disease that affects nearly 200,000 people in the United States. According to a publication by the National Library of Medicine, Diclofenac 3% gel is a potential treatment for DSAP, thereby increasing its use.

Increasing Demand for Aesthetic Products

The benefits of the provided treatment improved the aesthetic appearance, performance, and removal of the malformed lesions. The porokeratosis treatment is highly dependent on factors such as the size of the wound, its location, the patient's aesthetic preferences, the availability of treatment, and the appearance of the wound. The demand for porokeratosis treatment has increased as a result of rising income and improved and expanded knowledge of aesthetics. Consequently, consumers increasingly view porokeratosis treatment as a necessary tool for leading a healthier lifestyle. The topical products are in high demand due to their accessibility and ease of use. Due to its high price, laser therapy is popular among affluent consumers. No incision or hospitalization is required, which contributes to its popularity and makes it a more popular therapy for the treatment of porokeratosis.

Consumers are increasingly concerned with aesthetics, particularly in developed nations where disposable income and reimbursement regulations are increasing. Consumers in developed nations are becoming aware of the disease's malignant transformation. The market for porokeratosis will expand as the demand for personal care increases. There is sufficient clinical surveillance to comprehend porokeratosis' malignant transformation. This awareness has increased the demand for porokeratosis treatments. However, the majority of awareness is currently in developed nations, but the market and awareness are rapidly expanding in developing nations as a result of the improved global dissemination of knowledge.

Side Effects Reported During Therapy

Laser treatment side effects include mild erythema, slight hyperpigmentation, and contemporary edema. According to dermentz.org, no treatment has proven to be effective over the long term, which increases patients' reluctance to undergo treatment. In addition, the high cost of treatment and people's lack of knowledge about skin treatments are other factors that inhibit the growth of porokeratosis treatment.

Laser Therapy to be the Fastest-Growing Market

Porokeratosis has become increasingly treated with laser therapy. The physician destroys the area of the skin with a laser device, allowing new skin to grow in its place. According to an article by Amarateedha Prak LeCourt, patients with various types of porokeratosis who underwent laser therapy experienced positive outcomes. One patient with linear porokeratosis, for instance, exhibited improvement when 585 nm flashlamp-pumped pulsed eye laser was administered. Another individual with DSAP responded positively to laser therapy. As laser therapy is risk-free and has no associated downtime or morbidity with pigment or textural changes, its adoption could contribute to the expansion of porokeratosis treatment.

Hospitals to Remain Dominant Segment Among the Market by End User

Hospitals represent a significant market opportunity for porokeratosis treatment. Hospitals are prominent centers for the diagnosis and treatment of porokeratosis, and they provide a comprehensive array of services, including diagnostic testing, medical and surgical treatment, and follow-up care. This can lead to increased revenue opportunities for hospitals. Utilizing the most recent technologies and developments in porokeratosis treatment, hospitals can improve patient outcomes and attract more patients. Therefore, hospitals are well-positioned to capitalize on the growing demand for effective porokeratosis treatments.

North America Remains as the Global Leader

The growth of the porokeratosis treatment market in North America is influenced by factors such as the condition's rising prevalence, rising awareness among healthcare professionals and patients, and the availability of novel treatments and therapies. The market is anticipated to be dominated by North America due to the increasing prevalence of DSAP and the number of renal transplants. According to sciencedirect.com, the incidence of porokeratosis has increased alongside the number of kidney transplant patients.

According to niddk.nih.gov, more than 661,000 Americans have kidney failure and more than 468,000 patients are on dialysis, which may impact porokeratosis cases as 10% of patients with kidney problems have the disease. Asia's contribution to the growth of the market is influenced by the expansion of healthcare infrastructure and expenditures. In addition, Japan's aging population has led to an increase in cases of the disease in the country. In Asia, DSAP and Mibelli are the most prevalent types of porokerarosis.

People's lack of knowledge about the treatment is the cause of the increase in cases; therefore, the government should take steps to help people in rural areas gain knowledge about the treatment, which could lead to a rise in treatment adoption. Europe is in second place in the porokeratosis market due to the fact that rising incidences and innovations by researchers and manufacturers are driving market expansion. Increasing participation by manufacturers in the treatment of porokeratosis may stimulate market growth.

Investment in R&D to Enhance Market Share

The producers of porokeratosis treatments employ a variety of expansion strategies to increase their market share in the global protein markets. According to the increased funding for the treatment of porokeratosis, key players are actively investing in more effective and superior treatments for porokeratosis. Key players are investing in the development and introduction of a superior and cost-effective product for the porokeratosis treatment market, particularly in developing nations where aesthetic spending is still relatively low. With an increase in funding for porokeratosis treatment and the subsequent rise in product launches, there is intense competition among the major players.

Market leaders include: Coherent Inc., Alma Lasers, Almirall, Allergan, Pfizer, Lumenis, Coty Inc., Cutera, Bioness Inc., Biogen, PhotoMedex Inc., Valeant Pharmaceuticals, Hologic Inc., IPG Photonics Corporation, IRIDEX Corp.

The FDA approved Almirall's new topical treatment for actinic keratosis, tirbanibulin, in December 2020. Tirbanibulin is a novel microtubule that must be administered once every five days. In one of the largest Phase III clinical study programs for Actinic Keratosis lesions, tirbanibulin demonstrated efficacy in 57 days on the face and scalp of a large number of patients. In January 2021, Hologic, a global leader in women's health, announced the acquisition of Biotheranostics, Inc. This company is in the commercialization phase and offers molecular diagnostic tests for breast and metastatic cancers. The goal of the acquisition is to leverage commercial capabilities, accelerate growth, provide more personalized treatment, and improve clinical outcomes for women.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Porokeratosis Treatment market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Porokeratosis Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • Disseminated superficial actinic porokeratosis
  • Disseminated superficial porokeratosis
  • Surface treatment porokeratosis of mibelli
  • Injectable linear porokeratosis
  • Eruptive disseminated porokeratosis
  • Porokeratosis plantaris palmaris et disseminata
  • Punctate porokeratosis
  • Porokeratosis ptychotropica
  • Penoscrotal porokeratosis
  • Follicular porokeratosis

Diagnosis

  • Biopsy
  • Differential diagnosis
  • Squamous cell carcinoma
  • Lichenoid keratosis
  • Epidermal nevus
  • Others

Treatment

  • Topical therapies
  • Topical 5-fluorouracil
  • Topical imiquimod
  • Topical retinoids
  • Topical vitamin D analogs
  • Combination therapy
  • Systemic therapy
  • Oral retinoids
  • Physical interventions
  • Cryotherapy
  • electrodesiccation and curettage
  • surgical excision
  • dermabrasion
  • Laser Therapy
  • Carbon dioxide lasers
  • Q-switched ruby laser
  • Nd:YAG laser
  • Pulsed dye laser therapy

End-user

  • Hospitals
  • Clinics
  • Pharmacies and drug stores
  • Diagnostic Centers
  • Research and academic institutes
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Porokeratosis Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Porokeratosis Treatment market?
  • Which is the largest regional market for Porokeratosis Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Porokeratosis Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Porokeratosis Treatment market worldwide?
Show more
Product Code: 139509-04-23

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Porokeratosis Treatment Market
  • 2.2. Global Porokeratosis Treatment Market, By Type, 2022 (US$ Million)
  • 2.3. Global Porokeratosis Treatment Market, By Diagnosis, 2022 (US$ Million)
  • 2.4. Global Porokeratosis Treatment Market, By Treatment, 2022 (US$ Million)
  • 2.5. Global Porokeratosis Treatment Market, By End-user, 2022 (US$ Million)
  • 2.6. Global Porokeratosis Treatment Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. Porokeratosis Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Porokeratosis Treatment Market Vendors
  • 3.2. Strategies Adopted by Porokeratosis Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Porokeratosis Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Porokeratosis Treatment Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Disseminated superficial actinic porokeratosis
    • 5.3.2. Disseminated superficial porokeratosis
    • 5.3.3. Surface treatment porokeratosis of mibelli
    • 5.3.4. Injectable linear porokeratosis
    • 5.3.5. Eruptive disseminated porokeratosis
    • 5.3.6. Porokeratosis plantaris palmaris et disseminata
    • 5.3.7. Punctate porokeratosis
    • 5.3.8. Porokeratosis ptychotropica
    • 5.3.9. Penoscrotal porokeratosis
    • 5.3.10. Follicular porokeratosis

6. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Biopsy
    • 6.3.2. Differential diagnosis
      • 6.3.2.1. Squamous cell carcinoma
      • 6.3.2.2. Lichenoid keratosis
      • 6.3.2.3. Epidermal nevus
    • 6.3.3. Others

7. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Topical therapies
      • 7.3.1.1. Topical 5-fluorouracil
      • 7.3.1.2. Topical imiquimod
      • 7.3.1.3. Topical retinoids
      • 7.3.1.4. Topical vitamin D analogs
      • 7.3.1.5. Combination therapy
    • 7.3.2. Systemic therapy
      • 7.3.2.1. Oral retinoids
    • 7.3.3. Physical interventions
      • 7.3.3.1. Cryotherapy
      • 7.3.3.2. electrodesiccation and curettage
      • 7.3.3.3. surgical excision
      • 7.3.3.4. dermabrasion
    • 7.3.4. Laser Therapy
      • 7.3.4.1. Carbon dioxide lasers
      • 7.3.4.2. Q-switched ruby laser
      • 7.3.4.3. Nd:YAG laser
      • 7.3.4.4. Pulsed dye laser therapy

8. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Pharmacies and drug stores
    • 8.3.4. Diagnostic Centers
    • 8.3.5. Research and academic institutes
    • 8.3.6. Others

9. North America Porokeratosis Treatment Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
  • 9.3. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
  • 9.4. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
  • 9.5. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
  • 9.6.Porokeratosis Treatment Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.6.1.1.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 9.6.1.1.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 9.6.1.1.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.6.1.2.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 9.6.1.2.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 9.6.1.2.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.6.1.3.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 9.6.1.3.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 9.6.1.3.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

10. UK and European Union Porokeratosis Treatment Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
  • 10.3. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
  • 10.4. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
  • 10.5. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
  • 10.6.Porokeratosis Treatment Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.1.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.1.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.1.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.2.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.2.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.2.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.3.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.3.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.3.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.4.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.4.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.4.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.5.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.5.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.5.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.6.1.6.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 10.6.1.6.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 10.6.1.6.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

11. Asia Pacific Porokeratosis Treatment Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
  • 11.3. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
  • 11.4. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
  • 11.5. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
  • 11.6.Porokeratosis Treatment Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.1.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.1.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.1.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.2.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.2.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.2.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.3.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.3.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.3.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.4.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.4.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.4.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.5.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.5.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.5.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.6.1.6.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 11.6.1.6.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 11.6.1.6.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

12. Latin America Porokeratosis Treatment Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
  • 12.3. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
  • 12.4. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
  • 12.5. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
  • 12.6.Porokeratosis Treatment Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 12.6.1.1.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 12.6.1.1.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 12.6.1.1.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 12.6.1.2.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 12.6.1.2.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 12.6.1.2.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 12.6.1.3.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 12.6.1.3.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 12.6.1.3.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

13. Middle East and Africa Porokeratosis Treatment Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
  • 13.3. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
  • 13.4. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
  • 13.5. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
  • 13.6.Porokeratosis Treatment Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 13.6.1.1.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 13.6.1.1.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 13.6.1.1.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 13.6.1.2.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 13.6.1.2.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 13.6.1.2.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Porokeratosis Treatment Market: By Type, 2021-2031, USD (Million)
        • 13.6.1.3.1. Porokeratosis Treatment Market: By Diagnosis, 2021-2031, USD (Million)
        • 13.6.1.3.1. Porokeratosis Treatment Market: By Treatment, 2021-2031, USD (Million)
        • 13.6.1.3.1. Porokeratosis Treatment Market: By End-user, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Coherent Inc.
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Alma Lasers
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Almirall
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Allergan
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Pfizer
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Lumenis
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Coty Inc.
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Cutera
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Bioness Inc.
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Biogen
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. PhotoMedex Inc.
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. Valeant Pharmaceuticals
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives
  • 14.13. Hologic Inc.
    • 14.13.1. Company Overview
    • 14.13.2. Financial Performance
    • 14.13.3. Product Portfolio
    • 14.13.4. Strategic Initiatives
  • 14.14. IPG Photonics Corporation
    • 14.14.1. Company Overview
    • 14.14.2. Financial Performance
    • 14.14.3. Product Portfolio
    • 14.14.4. Strategic Initiatives
  • 14.15. IRIDEX Corp.
    • 14.15.1. Company Overview
    • 14.15.2. Financial Performance
    • 14.15.3. Product Portfolio
    • 14.15.4. Strategic Initiatives
  • 14.16. Others
    • 14.16.1. Company Overview
    • 14.16.2. Financial Performance
    • 14.16.3. Product Portfolio
    • 14.16.4. Strategic Initiatives
Show more
Product Code: 139509-04-23

List of Tables

  • TABLE 1 Global Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 2 Global Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 3 Global Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 4 Global Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 5 Global Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 6 Global Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 7 Global Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 8 Global Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 9 Global Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 10 North America Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 11 North America Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 12 North America Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 13 North America Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 14 North America Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 15 North America Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 16 North America Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 17 North America Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 18 North America Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 19 U.S. Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 20 U.S. Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 21 U.S. Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 22 U.S. Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 23 U.S. Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 24 U.S. Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 25 U.S. Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 26 U.S. Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 27 U.S. Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 28 Canada Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 29 Canada Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 30 Canada Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 31 Canada Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 32 Canada Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 33 Canada Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 34 Canada Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 35 Canada Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 36 Canada Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 37 Rest of North America Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 38 Rest of North America Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 39 Rest of North America Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 40 Rest of North America Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 41 Rest of North America Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 42 Rest of North America Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 43 Rest of North America Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 44 Rest of North America Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 45 Rest of North America Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 46 UK and European Union Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 47 UK and European Union Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 48 UK and European Union Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 49 UK and European Union Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 50 UK and European Union Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 51 UK and European Union Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 52 UK and European Union Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 53 UK and European Union Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 54 UK and European Union Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 55 UK Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 56 UK Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 57 UK Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 58 UK Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 59 UK Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 60 UK Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 61 UK Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 62 UK Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 63 UK Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 64 Germany Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 65 Germany Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 66 Germany Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 67 Germany Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 68 Germany Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 69 Germany Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 70 Germany Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 71 Germany Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 72 Germany Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 73 Spain Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 74 Spain Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 75 Spain Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 76 Spain Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 77 Spain Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 78 Spain Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 79 Spain Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 80 Spain Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 81 Spain Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 82 Italy Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 83 Italy Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 84 Italy Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 85 Italy Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 86 Italy Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 87 Italy Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 88 Italy Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 89 Italy Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 90 Italy Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 91 France Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 92 France Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 93 France Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 94 France Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 95 France Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 96 France Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 97 France Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 98 France Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 99 France Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 100 Rest of Europe Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 101 Rest of Europe Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 102 Rest of Europe Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 103 Rest of Europe Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 104 Rest of Europe Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 105 Rest of Europe Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 106 Rest of Europe Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 107 Rest of Europe Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 108 Rest of Europe Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 109 Asia Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 110 Asia Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 111 Asia Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 112 Asia Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 113 Asia Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 114 Asia Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 115 Asia Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 116 Asia Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 117 Asia Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 118 China Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 119 China Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 120 China Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 121 China Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 122 China Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 123 China Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 124 China Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 125 China Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 126 China Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 127 Japan Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 128 Japan Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 129 Japan Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 130 Japan Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 131 Japan Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 132 Japan Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 133 Japan Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 134 Japan Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 135 Japan Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 136 India Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 137 India Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 138 India Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 139 India Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 140 India Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 141 India Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 142 India Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 143 India Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 144 India Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 145 Australia Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 146 Australia Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 147 Australia Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 148 Australia Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 149 Australia Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 150 Australia Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 151 Australia Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 152 Australia Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 153 Australia Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 154 South Korea Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 155 South Korea Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 156 South Korea Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 157 South Korea Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 158 South Korea Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 159 South Korea Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 160 South Korea Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 161 South Korea Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 162 South Korea Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 163 Latin America Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 164 Latin America Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 165 Latin America Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 166 Latin America Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 167 Latin America Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 168 Latin America Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 169 Latin America Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 170 Latin America Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 171 Latin America Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 172 Brazil Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 173 Brazil Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 174 Brazil Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 175 Brazil Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 176 Brazil Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 177 Brazil Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 178 Brazil Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 179 Brazil Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 180 Brazil Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 181 Mexico Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 182 Mexico Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 183 Mexico Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 184 Mexico Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 185 Mexico Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 186 Mexico Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 187 Mexico Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 188 Mexico Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 189 Mexico Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 190 Rest of Latin America Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 191 Rest of Latin America Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 192 Rest of Latin America Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 193 Rest of Latin America Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 194 Rest of Latin America Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 195 Rest of Latin America Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 196 Rest of Latin America Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 197 Rest of Latin America Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 198 Rest of Latin America Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 199 Middle East and Africa Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 200 Middle East and Africa Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 201 Middle East and Africa Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 202 Middle East and Africa Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 203 Middle East and Africa Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 204 Middle East and Africa Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 205 Middle East and Africa Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 206 Middle East and Africa Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 207 Middle East and Africa Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 208 GCC Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 209 GCC Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 210 GCC Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 211 GCC Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 212 GCC Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 213 GCC Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 214 GCC Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 215 GCC Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 216 GCC Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 217 Africa Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 218 Africa Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 219 Africa Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 220 Africa Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 221 Africa Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 222 Africa Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 223 Africa Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 224 Africa Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 225 Africa Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)
  • TABLE 226 Rest of Middle East and Africa Porokeratosis Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 227 Rest of Middle East and Africa Porokeratosis Treatment Market By Diagnosis, 2021-2031, USD (Million)
  • TABLE 228 Rest of Middle East and Africa Porokeratosis Treatment Market By Differential diagnosis, 2021-2031, USD (Million)
  • TABLE 229 Rest of Middle East and Africa Porokeratosis Treatment Market By Treatment, 2021-2031, USD (Million)
  • TABLE 230 Rest of Middle East and Africa Porokeratosis Treatment Market By Topical therapies, 2021-2031, USD (Million)
  • TABLE 231 Rest of Middle East and Africa Porokeratosis Treatment Market By Systemic therapy, 2021-2031, USD (Million)
  • TABLE 232 Rest of Middle East and Africa Porokeratosis Treatment Market By Physical interventions, 2021-2031, USD (Million)
  • TABLE 233 Rest of Middle East and Africa Porokeratosis Treatment Market By Laser Therapy, 2021-2031, USD (Million)
  • TABLE 234 Rest of Middle East and Africa Porokeratosis Treatment Market By End-user, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Porokeratosis Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Porokeratosis Treatment Market: Quality Assurance
  • FIG. 5 Global Porokeratosis Treatment Market, By Type, 2022
  • FIG. 6 Global Porokeratosis Treatment Market, By Diagnosis, 2022
  • FIG. 7 Global Porokeratosis Treatment Market, By Treatment, 2022
  • FIG. 8 Global Porokeratosis Treatment Market, By End-user, 2022
  • FIG. 9 Global Porokeratosis Treatment Market, By Geography, 2022
  • FIG. 10 Market Geographical Opportunity Matrix - Global Porokeratosis Treatment Market, 2022
  • FIG. 11 Market Positioning of Key Porokeratosis Treatment Market Players, 2022
  • FIG. 12 Global Porokeratosis Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 13 Global Porokeratosis Treatment Market, By Type, 2022 Vs 2031, %
  • FIG. 14 Global Porokeratosis Treatment Market, By Diagnosis, 2022 Vs 2031, %
  • FIG. 15 Global Porokeratosis Treatment Market, By Treatment, 2022 Vs 2031, %
  • FIG. 16 Global Porokeratosis Treatment Market, By End-user, 2022 Vs 2031, %
  • FIG. 17 U.S. Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 18 Canada Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of North America Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 20 UK Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 21 Germany Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 22 Spain Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 23 Italy Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 24 France Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Europe Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 26 China Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 27 Japan Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 28 India Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 29 Australia Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 30 South Korea Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Asia Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 32 Brazil Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 33 Mexico Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 34 Rest of Latin America Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 35 GCC Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 36 Africa Porokeratosis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 37 Rest of Middle East and Africa Porokeratosis Treatment Market (US$ Million), 2021 - 2031
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!